CDER/CBER Budget & Acquisition Shared Services Support_Base
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $3,000,000 to $7,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- CDER Acquisition Liaison cderacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring dedicated support services to bridge Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) recurring and ad hoc budgetary and acquisitions requirements to the agency's new enterprise shared services model. The solicitation is estimated to release on September 1, 2026, with an award anticipated on March 1, 2027.
The estimated award value ranges from $3 million to $7 million. Work will support CDER/CBER Shared Services Team operations. Inquiries should be directed to the FDA Acquisition Liaison at cderacquisitions@fda.hhs.gov.
Forecast text
The Food and Drug Administration (FDA)CDER/CBER Shared Services Team is seeking dedicated, specialized support to bridge specific OPI COP-level recurring and ad hoc budgetary and acquisitions requirements to the new enterprise shared services model.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast